Literature DB >> 22864266

Remote monitoring of cardiovascular devices: a time and activity analysis.

Edmond M Cronin1, Elizabeth A Ching, Niraj Varma, David O Martin, Bruce L Wilkoff, Bruce D Lindsay.   

Abstract

BACKGROUND: Expanding indications for cardiovascular implantable electronic devices are accompanied by an increasing burden of device clinic follow-up. Remote monitoring (RM) may be less time-consuming compared to in-office follow-up; however, its effect on the device clinic workflow has not been clarified.
OBJECTIVE: To determine the impact of RM on device clinic workflow.
METHODS: Detailed workflow data were prospectively collected over a 2-week period in a busy device clinic.
RESULTS: Five hundred remote transmissions were received from 434 patients between March 1 and March 16, 2011--346 implantable cardioverter-defibrillator, 84 pacemaker, and 70 implantable loop recorder transmissions--on 4 RM platforms (CareLink 56.4%, Merlin.net 21.4%, LATITUDE 17.8%, and Home Monitoring 4.4%). The mean time spent per transmission was 11.5 ± 7.7 minutes, which was less than in-person interrogations (27.7 ± 9.9 minutes; P <.01). Of 500 transmissions, 135 (27.0%) demonstrated clinically important findings; however, only 41 (8.2%) were forwarded for physician review. Of 500 transmissions, 138 (27.6%) were unscheduled, and these were more likely to contain a clinically important event (56 of 138 [40.6%] vs 79 of 362 [21.8%]; P = .0001). A total of 5.8% of the transmissions were duplicate. Transmissions that revealed clinically important findings took longer to process than those that did not (21.0 ± 7.4 minutes vs 10.1 ± 2.1 minutes; P <.05). A total of 49.2% of the scheduled remote transmissions were missed because of patient noncompliance. Telephone follow-up of patients (mean 21 patients/d) who missed scheduled remote transmissions took a mean of 55.1 (range 20-98) min/d.
CONCLUSIONS: Analysis of RM transmissions has significant implications for the device clinic workflow. Nonactionable transmissions are rapidly processed, allowing clinicians to focus on clinically important findings. However, poor patient compliance complicates the workflow efficiency of currently available systems.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22864266     DOI: 10.1016/j.hrthm.2012.08.002

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  17 in total

1.  Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up.

Authors:  Loredana Morichelli; Antonio Porfili; Laura Quarta; Anna Sassi; Renato Pietro Ricci
Journal:  J Interv Card Electrophysiol       Date:  2014-09-26       Impact factor: 1.900

2.  A prospective comparison of remote monitoring systems in implantable cardiac defibrillators: potential effects of frequency of transmissions.

Authors:  Ermenegildo de Ruvo; Luigi Sciarra; Anna Maria Martino; Marco Rebecchi; Renzo Venanzio Iulianella; Francesco Sebastiani; Alessandro Fagagnini; Alessio Borrelli; Antonio Scarà; Domenico Grieco; Claudia Tota; Federica Stirpe; Leonardo Calò
Journal:  J Interv Card Electrophysiol       Date:  2016-01       Impact factor: 1.900

Review 3.  Remote monitoring of cardiac implantable electronic devices (CIED).

Authors:  Emily P Zeitler; Jonathan P Piccini
Journal:  Trends Cardiovasc Med       Date:  2016-03-31       Impact factor: 6.677

4.  Remote Monitoring for Follow-up of Patients with Cardiac Implantable Electronic Devices.

Authors:  Renato Pietro Ricci; Loredana Morichelli; Niraj Varma
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

5.  Remote monitoring for implantable defibrillators: a nationwide survey in Italy.

Authors:  Mario Luzi; Antonio De Simone; Loira Leoni; Claudia Amellone; Ennio Pisanò; Stefano Favale; Massimo Iacoviello; Raffaele Luise; Maria Grazia Bongiorni; Giuseppe Stabile; Vincenzo La Rocca; Franco Folino; Alessandro Capucci; Antonio D'Onofrio; Francesco Accardi; Sergio Valsecchi; Gianfranco Buia
Journal:  Interact J Med Res       Date:  2013-09-20

6.  Performance of a remote interrogation system for the in-hospital evaluation of cardiac implantable electronic devices.

Authors:  Suneet Mittal; Kevin Younge; Kelly King-Ellison; Eric Hammill; Kenneth Stein
Journal:  J Interv Card Electrophysiol       Date:  2015-12-22       Impact factor: 1.900

7.  Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems.

Authors:  Niraj Varma; Behzad B Pavri; Bruce Stambler; Justin Michalski
Journal:  Europace       Date:  2012-12-19       Impact factor: 5.214

Review 8.  Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK.

Authors:  Haran Burri; Christian Sticherling; David Wright; Koji Makino; Antje Smala; Dominic Tilden
Journal:  Europace       Date:  2013-04-18       Impact factor: 5.214

Review 9.  Telemedicine and cardiac implants: what is the benefit?

Authors:  Niraj Varma; Renato Pietro Ricci
Journal:  Eur Heart J       Date:  2012-12-04       Impact factor: 29.983

10.  Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations.

Authors:  Niraj Varma; Justin Michalski; Bruce Stambler; Behzad B Pavri
Journal:  Eur Heart J       Date:  2014-03-03       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.